Group-based Family Cognitive-Behavioural Therapy for Pediatric OCD
Clinical Outcomes Following Group-based Family Cognitive-Behaviour Therapy in Pediatric Obsessive-Compulsive Disorder (OCD)
This study tests whether a new group therapy that includes families can help children and teens with Obsessive-Compulsive Disorder feel better and improve their family life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 180 (estimated) |
| Ages | 5 Years to 18 Years |
| Sex | All |
| Sponsor | University of British Columbia Academic / other |
| Locations | 1 site (Vancouver, British Columbia) |
| Trial ID | NCT01635569 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of Group-based Family Cognitive-Behavioural Therapy (GF-CBT) for children and adolescents with Obsessive-Compulsive Disorder (OCD). The study involves two groups: one receiving GF-CBT treatment and another on a waitlist for treatment. Clinical outcomes related to OCD severity and family functioning will be measured at multiple time points to assess the impact of the therapy. The aim is to include parents in the treatment process, addressing a gap in traditional OCD therapies.
Who should consider this trial
Good fit: Ideal candidates are children and adolescents aged 5-18 years with a diagnosis of moderate to severe OCD.
Not a fit: Patients with co-occurring severe mental health conditions such as bipolar disorder or psychosis may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve treatment access and outcomes for children with OCD and their families.
How similar studies have performed: Previous studies have shown promise in using family-inclusive approaches for treating pediatric OCD, suggesting potential success for this novel GF-CBT method.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female, aged 5-18 years old * Ability of subject and parent to provide informed assent/consent * English-speaking * Current DSM IV-TR Axis I diagnosis of childhood-onset OCD; Moderate to severe OCD (CY-BOCS≥16/40) Exclusion Criteria: * Current diagnosis of bipolar disorder, psychosis, mental retardation or pervasive developmental disorder (e.g., autism), and current or past substance dependence/abuse
Where this trial is running
Vancouver, British Columbia
- BC Children's Hospital Research Institute — Vancouver, British Columbia, Canada (Recruiting)
Study contacts
- Principal investigator: S. Evelyn Stewart, MD — University of British Columbia
- Study coordinator: Diana Franco Yamin, MA
- Email: dfrancoy@bcchr.ca
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.